Cargando…
Potential role of lampalizumab for treatment of geographic atrophy
The purpose of this article is to review the pathways underlying age-related macular degeneration and potential therapeutic targets, focusing on the complement pathway and the recent MAHALO Phase II trial of the investigational drug lampalizumab. This trial was the first to have shown positive resul...
Autores principales: | Rhoades, William, Dickson, Drew, Do, Diana V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468985/ https://www.ncbi.nlm.nih.gov/pubmed/26089637 http://dx.doi.org/10.2147/OPTH.S59725 |
Ejemplares similares
-
Potential role of lampalizumab for treatment of geographic atrophy [Retraction]
Publicado: (2015) -
Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy
por: Le, KN, et al.
Publicado: (2015) -
Management of macular edema due to central retinal vein occlusion – The role of aflibercept
por: Rhoades, William, et al.
Publicado: (2017) -
Alternative Complement Pathway Inhibition by Lampalizumab: Analysis of Data From Chroma and Spectri Phase III Clinical Trials
por: Edmonds, Rose, et al.
Publicado: (2023) -
Treating patients with geographic atrophy: are we there yet?
por: Antonio-Aguirre, Bani, et al.
Publicado: (2023)